Risankizumab is effective in inducing clinical and endoscopic remission and is generally well tolerated in patients with Crohn’s disease, a real-world study shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/risankizumab-effective-crohns-real-world-data-show-2026a10005yg?src=rss
Author :
Publish date : 2026-02-27 12:00:00
Copyright for syndicated content belongs to the linked Source.
